G protein-mediated Ca2+-sensitization of CPI-17 phosphorylation in arterial smooth muscle

Biochemical and Biophysical Research Communications

Volumn 401, Issue 1, 2010, Pages 75-78

  Kitazawa, Toshio ^a  

^a BOSTON BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Artery; Calcium sensitivity; CPI 17; Myosin phosphatase; Protein kinase C; Smooth muscle

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; ALPHA TOXIN; CALCIMYCIN; CALCIUM; CALYCULIN A; CPI 17; EGTAZIC ACID; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); PHOSPHOPROTEIN; PROTEIN KINASE C ACTIVATOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTERY MUSCLE; ARTICLE; CALCIUM TRANSPORT; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SARCOPLASMIC RETICULUM; SMOOTH MUSCLE CONTRACTION;

ANIMALS; CALCIUM; CAPILLARY PERMEABILITY; CELLS, CULTURED; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MUSCLE CONTRACTION; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; PHOSPHOPROTEINS; PHOSPHORYLATION; RABBITS;

EID: 77957663118     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.09.011     Document Type: Article

References (15)

1. Kitazawa T., Eto M., Woodsome T.P., et al. Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. J. Biol. Chem. 2000, 275:9897-9900.
2. Eto M. Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 inhibitors. J. Biol. Chem. 2009, 284:35273-35277.
3. 2+ sensitization of contraction in arterial smooth muscle. Circ. Res. 2007, 100:121-129.
4. Kamm K.E., Stull J.T. Dedicated myosin light chain kinases with diverse cellular functions. J. Biol. Chem. 2001, 276:4527-4530.
5. 2+ sensitivity of protein kinase C-induced contraction in rabbit smooth muscle. J. Physiol. 2001, 535:553-564.
6. 2+-sensitizing effect of protein kinase C on vascular smooth muscle: inhibition of myosin light chain phosphatase. J. Gen. Physiol. 1994, 104:265-286.
7. 2+. J. Biol. Chem. 1989, 264:5339-5342.
8. 2+ sensitization in triton X-100-demembranated rabbit arterial smooth muscle. J. Physiol. 1999, 520:139-152.
9. 2+ sensitization of smooth muscle contraction through myosin light chain phosphorylation. J. Biol. Chem. 1991, 266:1708-1715.
10. Eto M., Kitazawa T., Brautigan D.L. Phosphoprotein inhibitor CPI-17 specificity depends on allosteric regulation of protein phosphatase-1 by regulatory subunits. Proc. Natl. Acad. Sci. USA 2004, 101:8888-8893.
11. Ishihara H., Martin B.L., Brautigan D.L., et al. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem. Biophys. Res. Commun. 1989, 159:871-877.
12. Eto M., Kitazawa T., Yazawa M., et al. Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms. J. Biol. Chem. 2001, 276:29072-29078.
13. Huang J., Mahavadi S., Sriwai W., et al. Gi-coupled receptors mediate phosphorylation of CPI-17 and MLC20 via preferential activation of the PI3K/ILK pathway. Biochem. J. 2006, 396:193-200.
14. MacDonald J.A., Eto M., Borman M.A., et al. Dual Ser and Thr phosphorylation of CPI-17, an inhibitor of myosin phosphatase, by MYPT-associated kinase. FEBS Lett. 2001, 493:91-94.
15. Takizawa N., Koga Y., Ikebe M. Phosphorylation of CPI17 and myosin binding subunit of type 1 protein phosphatase by p21-activated kinase. Biochem. Biophys. Res. Commun. 2002, 297:773-778.